RNWCX
Price
$76.15
Change
+$0.12 (+0.16%)
Updated
Dec 20 closing price
RNWHX
Price
$76.47
Change
+$0.12 (+0.16%)
Updated
Dec 20 closing price
Ad is loading...

RNWCX vs RNWHX

Header iconRNWCX vs RNWHX Comparison
Open Charts RNWCX vs RNWHXBanner chart's image
American Funds New World R3
Price$76.15
Change+$0.12 (+0.16%)
VolumeN/A
CapitalizationN/A
American Funds New World R5E
Price$76.47
Change+$0.12 (+0.16%)
VolumeN/A
CapitalizationN/A
RNWCX vs RNWHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWCX vs. RNWHX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWCX is a Buy and RNWHX is a Buy.

FUNDAMENTALS
Fundamentals
RNWCX (62.2B) and RNWHX (62.2B) have equal amount of cash in the bank . RNWHX pays higher dividends than RNWCX: RNWHX (1.44) vs RNWCX (1.00). RNWCX was incepted earlier than RNWHX: RNWCX (23 years) vs RNWHX (9 years). RNWCX (32.00) and RNWHX (32.00) have comparable annual turnover. RNWCX (250) and RNWHX (250) have matching initial minimum investment requirements. RNWHX annual gain was more profitable for investors over the last year : 5.71 vs. RNWCX (5.17). RNWHX return over 5 years is better than : 13.80 vs. RNWCX (11.93).
RNWCXRNWHXRNWCX / RNWHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years9 years-
Gain YTD3.8864.39488%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets62.2B62.2B100%
Annual Yield % from dividends1.001.4470%
Returns for 1 year5.175.7191%
Returns for 3 years-6.27-5.37117%
Returns for 5 years11.9313.8086%
Returns for 10 years39.15N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GEN27.830.38
+1.38%
Gen Digital
STGW6.82-0.06
-0.87%
Stagwell
CALM102.89-1.48
-1.42%
Cal-Maine Foods
ALTO1.48-0.05
-3.27%
Alto Ingredients
POAI0.69-0.03
-3.82%
Predictive Oncology